Full text is available at the source.
Abstract
A low-dose tirzepatide strategy is being evaluated for clinical feasibility in older adults with type 2 diabetes mellitus.
- The strategy targets older adults who manage type 2 diabetes in routine outpatient settings.
- Clinical feasibility is assessed to determine the practicality of its implementation.
- Older adults with type 2 diabetes may benefit from tailored dosing of tirzepatide.
Simplified